Related Experiment Video
Updated: Apr 26, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
22.0K
Neoadjuvant radiotherapy (5 × 5 Gy): immediate versus delayed surgery
Krzysztof Bujko1, Maciej Partycki, Lucyna Pietrzak
1The Maria Sklodowska-Curie Memorial Cancer Centre, 5, W. K. Roentgena, 02-781, Warsaw, Poland, bujko@coi.waw.pl.
Summary
Delayed surgery after 5 × 5 Gy radiotherapy improves pathological complete response rates. This approach is beneficial for elderly patients unfit for chemotherapy and for managing unresectable or early-stage cancers.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- The optimal timing of surgery following short-course radiotherapy (SCRT) remains a subject of investigation.
- Understanding the impact of the interval between SCRT and surgery is crucial for treatment optimization.
Purpose of the Study:
- To systematically review and evaluate the role of the interval length between 5 × 5 Gy radiotherapy and surgical intervention.
- To assess the influence of delayed surgery on treatment outcomes, toxicity, and oncological results.
Main Methods:
- A systematic review was conducted using PubMed to identify relevant studies.
- Included studies analyzed outcomes for patients undergoing surgery after 5 × 5 Gy radiotherapy, comparing immediate versus delayed surgical approaches.
Main Results:
- Delayed surgery after 5 × 5 Gy radiotherapy was associated with a higher pathological complete response (pCR) rate (approximately 10% higher).
- Immediate surgery showed a lower rate of severe acute post-radiation toxicity but a higher incidence of minor postoperative complications.
- Short-course radiotherapy with delayed surgery demonstrated favorable outcomes in elderly patients unfit for chemotherapy and in cases of unresectable or early-stage cancers.
Conclusions:
- Delayed surgery following 5 × 5 Gy radiotherapy is a viable strategy for elderly patients unfit for chemotherapy with unresectable or early-stage cancers.
- Short-course radiotherapy combined with consolidation chemotherapy presents a promising treatment option for potentially resectable stage IV disease, achieving higher pCR rates.

